글로버스메디컬(주)
MX ˙ BMV ˙ US3795772082
SecurityMX:GMED / Globus Medical, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership14,167 shares
Latest Disclosed Value $ 1,220,629
Alps Advisors Inc reports 18.47% decrease in ownership of GMED / Globus Medical, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 14,167 shares of Globus Medical, Inc. (MX:GMED) valued at $1,220,629 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 17,376 shares of Globus Medical, Inc.. This represents a change in shares of -18.47% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F GLOBUS MED CL A 379577208 14,167 -3,209 -18.47 1,221 -19.58 0.0057
2026-02-12 2025-12-31 13F GLOBUS MED CL A 379577208 17,376 -4,985 -22.29 1,517 18.52 0.0088
2025-11-05 2025-09-30 13F GLOBUS MED CL A 379577208 22,361 8,440 60.63 1,281 55.91 0.0071
2025-08-11 2025-06-30 13F GLOBUS MED CL A 379577208 13,921 1,939 16.18 822 -6.39 0.0047
2025-04-30 2025-03-31 13F GLOBUS MED CL A 379577208 11,982 678 6.00 877 -6.10 0.0051
2025-02-13 2024-12-31 13F GLOBUS MED CL A 379577208 11,304 -1,506 -11.76 935 1.97 0.0059
2024-11-12 2024-09-30 13F GLOBUS MED CL A 379577208 12,810 12,810 916 0.0061
2022-05-13 2022-03-31 13F GLOBUS MED CL A 379577208 0 -4,621 -100.00 0 -100.00
2022-02-09 2021-12-31 13F GLOBUS MED CL A 379577208 4,621 92 2.03 334 -3.75 0.0038
2021-11-15 2021-09-30 13F GLOBUS MED CL A 379577208 4,529 4,529 347 0.0033
2020-11-05 2020-09-30 13F/A-1 GLOBUS MED CL A 379577208 0 -5,052 -100.00 0 -100.00
2020-11-04 2020-09-30 13F GLOBUS MED CL A 379577208 0 0
2020-08-05 2020-06-30 13F GLOBUS MED CL A 379577208 5,052 -564 -10.04 241 0.84 0.0032
2020-05-06 2020-03-31 13F GLOBUS MED CL A 379577208 5,616 5,616 239 0.0037
2019-11-04 2019-09-30 13F GLOBUS MEDICAL I COMMON STOCK 379577208 0 -8,307 -100.00 0 -100.00
2019-08-07 2019-06-30 13F GLOBUS MEDICAL I COMMON STOCK 379577208 8,307 -439 -5.02 351 -18.75 0.0026
2019-05-01 2019-03-31 13F GLOBUS MEDICAL I COMMON STOCK 379577208 8,746 8,746 432 0.0031
2018-10-25 2018-09-30 13F Globus Medical COMMON STOCK 379577208 0 -15,299 -100.00 0 -100.00
2018-07-31 2018-06-30 13F/A-1 Globus Medical COMMON STOCK 379577208 15,299 15,299 629 0.0040
2018-07-25 2018-06-30 13F Globus Medical COMMON STOCK 379577208 15,299 15,299 629
2018-05-01 2018-03-31 13F Globus Medical COMMON STOCK 379577208 0 -15,299 -100.00 0 -100.00
2018-02-20 2017-12-31 13F/A-1 Globus Medical COMMON STOCK 379577208 15,299 0 0.00 629 38.24 0.0044
2018-02-05 2017-12-31 13F Globus Medical COMMON STOCK 379577208 15,299 0 629
2017-11-03 2017-09-30 13F Globus Medical COMMON STOCK 379577208 15,299 -2,165 -12.40 455 -21.42 0.0032
2017-08-03 2017-06-30 13F Globus Medical COMMON STOCK 379577208 17,464 45 0.26 579 12.21 0.0040
2017-05-12 2017-03-31 13F Globus Medical COMMON STOCK 379577208 17,419 -1,029 -5.58 516 12.66 0.0036
2017-01-24 2016-12-31 13F Globus Medical Common Stock 379577208 18,448 176 0.96 458 11.17 0.0034
2016-11-02 2016-09-30 13F Globus Medical Inc Common Stock 379577208 18,272 2,144 13.29 412 7.29 0.0034
2016-07-27 2016-06-30 13F Globus Medical Inc Common Stock 379577208 16,128 -1,184 -6.84 384 -6.57 0.0034
2016-05-10 2016-03-31 13F Globus Medical Inc Common Stock 379577208 17,312 -3,446 -16.60 411 -28.77 0.0042
2016-02-05 2015-12-31 13F Globus Medical Inc Common Stock 379577208 20,758 0 0.00 577 -86.55 0.0056
2015-11-13 2015-09-30 13F Globus Medical Inc Common Stock 379577208 20,758 -409 -1.93 4,289 689.87 0.0045
2015-08-12 2015-06-30 13F GLOBUS MEDICAL INC - A Common Stock 379577208 21,167 329 1.58 543 3.23 0.0046
2015-05-15 2015-03-31 13F GLOBUS MEDICAL INC - A Common Stock 379577208 20,838 -5,700 -21.48 526 -16.64 0.0043
2015-02-13 2014-12-31 13F GLOBUS MEDICAL INC - A Common Stock 379577208 26,538 -3,762 -12.42 631 5.87 0.0050
2014-12-18 2014-09-30 13F/A-1 GLOBUS MEDICAL INC - A Common Stock 379577208 30,300 30,300 596 0.0046
2014-11-24 2014-09-30 13F GLOBUS MEDICAL INC - A Common Stock 379577208 30,300 596
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.